Previous Article | Next Article ![]()
Infect. Immun., Jul 1996, 2400-2407, Vol 64, No. 7
CL Silva, MF Silva, RC Pietro and DB Lowrie
Mice vaccinated by injection with tumor cells expressing the Mycobacterium
leprae gene for hsp65 acquire a remarkably high degree of protection
against challenge with Mycobacterium tuberculosis. We used
limiting-dilution analysis to assess the frequency of CD4+ CD8- and CD4-
CD8+ splenocytes responding to mycobacterial hsp65 in such vaccinated mice.
Cells of both phenotypes were present at very high and equal frequencies
(approximately 1:100). Vaccination with live Mycobacterium bovis BCG also
increased the frequencies of both phenotypes of hsp65- reactive cells
equally (to approximately 1:2,500), whereas vaccination procedures that
were not protective, with either dead BCG, hsp65 protein in incomplete
Freund's adjuvant, or hsp65 mixed with tumor cells, resulted in
preferential increase in CD4+ CD8- cells. Twelve CD4+ CD8- and twelve CD4-
CD8+ hsp65-responsive T-cell clones were obtained and characterized. All
showed conventional antigen recognition via major histocompatibility
complex class II and class I pathways but differed in secretion of gamma
interferon and interleukin 4 and cytotoxicity. In tests of
antimycobacterial activity against M. tuberculosis, both in infected
macrophages in vitro and by adoptive transfer of protection with T-cell
clones injected into irradiated mice, the most effective clones were the
most cytotoxic and secretion of gamma interferon made only a secondary
contribution.
Copyright © 1996, American Society for Microbiology
Characterization of T cells that confer a high degree of protective immunity against tuberculosis in mice after vaccination with tumor cells expressing mycobacterial hsp65
Department of Parasitology, Microbiology and Immunology, School of Medicine of Ribeirao Preto, University of Sao Paulo, Brazil.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|